EPW
WST icon

Evolve Private Wealth’s West Pharmaceutical WST Stock Holding History

Evolve Private Wealth’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Buy
+689
New +$211K 0.02% 831
2026
Q1 		– Sell
-1,057
Closed -$291K – 1062
2025
Q4 		$291K Buy
+1,057
New +$289K 0.02% 737

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Evolve Private Wealth's WST Position: Q2 2026 in Review

Evolve Private Wealth opened a new position in West Pharmaceutical (WST) in Q2 2026: 689 shares worth $247K. The stake represents 0.02% of the portfolio and ranks #831 among its holdings. This is a return to the name: Evolve Private Wealth previously reported a position in WST as recently as Q4 2025.

Evolve Private Wealth first reported a position in WST in Q4 2025 and has held it in 2 quarters since. The position peaked at $291K in Q4 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Evolve Private Wealth held 689 shares of West Pharmaceutical worth $247K as of Q2 2026.
  • West Pharmaceutical was a new Evolve Private Wealth position in Q2 2026.
  • West Pharmaceutical made up 0.02% of Evolve Private Wealth's portfolio in Q2 2026, its #831 holding.
  • Evolve Private Wealth first reported a position in West Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • Evolve Private Wealth's West Pharmaceutical position peaked at $291K in Q4 2025.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.